Showing results (111-120 of 236) with videos related to
Sort By:
Pageof 24
Viruses|September 23, 2022
Obesity and Dysmetabolic Factors among Deceased COVID-19 Adults under 65 Years of Age in Italy: A Retrospective Case-Control StudyLoreta A Kondili, Maria Giovanna Quaranta, Mauro Viganò, et al.Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 30, 2014
Liver fibrosis, microbial translocation and immune activation markers in HIV and HCV infections and in HIV/HCV co-infectionPaolo Sacchi, Serena Cima, Marta Corbella, et al.Liver International : Official Journal of the International Association for the Study of the Liver|August 31, 2023
Is HCV elimination among persons living with HIV feasible? Data from the NoCo study in the setting of the ICONA cohortAntonella d'Arminio Monforte, Alessandro Tavelli, Roberto Rossotti, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 6, 2006
Influence of genotype 3 hepatitis C coinfection on liver enzyme elevation in HIV-1-positive patients after commencement of a new highly active antiretroviral regimen: results from the EPOKA-MASTER CohortCarlo Torti, Giuseppe Lapadula, Massimo Puoti, et al.Antiviral Therapy|December 18, 2013
Strategies for assignment of HIV-HCV genotype-1-coinfected patients to either dual-therapy or direct-acting antiviral agent-based triple-therapyMattias Mandorfer, Karin Neukam, Antonio Rivero, et al.European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 11, 2018
Incidence and predictors of single drug discontinuation according to the presence of HCV coinfection in HIV patients from the ICONA Foundation Cohort StudySebastiano Leone, Milensu Shanyinde, Alessandro Cozzi Lepri, et al.Therapeutics and Clinical Risk Management|August 10, 2023
Analysis of Patients' Characteristics and Treatment Profile of People Who Use Drugs (PWUDs) with and without a Co-Diagnosis of Viral Hepatitis C: A Real-World Retrospective Italian AnalysisFelice Alfonso Nava, Alessandra Mangia, Marco Riglietta, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 25, 2016
Efficacy and Safety of Ledipasvir/Sofosbuvir With and Without Ribavirin in Patients With Chronic HCV Genotype 1 Infection Receiving Opioid Substitution Therapy: Analysis of Phase 3 ION TrialsJason Grebely, Stefan Mauss, Ashley Brown, et al.Liver International : Official Journal of the International Association for the Study of the Liver|February 5, 2015
Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1-coinfected patientsPatrick Miailhes, Camille Gilbert, Karine Lacombe, et al.European Journal of Radiology|December 11, 2025
MRI‑based scoring system to predict spondylodiscitis: The SPONDY-ScoreDomenico Albano, Caterina Beatrice Monti, Giulia Blanda, et al.Pageof 24